期刊文献+

新的匀相清除法测定血清高密度脂蛋白胆固醇

New Homogenous Assay for Measruing Serum High Density Lipoprotein Cholesterol
在线阅读 下载PDF
导出
摘要 为建立利用混合表面活性剂做为抑制剂测定血清高密度脂蛋白胆固醇的新匀相法,将血清标本中的LDL-C、VLDL-C、CM等脂蛋白组分用HLB值为13.2的混合表面活性剂特异性清除,仅剩余HDL-C裂解参加胆固醇反应。结果表明,该法的线性区间为3.90 mmol/L;回收率为96.2%~103.7%;批内变异系数(CV)和批间变异系数(CV)分别为0.65%~2.88%、1.25%~3.56%;该法与参考方法回归方程及相关系数分别为y=1.010 2 x+0.078 8,r=0.976 2,相关性良好;当c(LDL-C)<12.8 mmol/L、c(TG)<12 mmol/L、ρ(胆红素)<320 mg/L、ρ(血红蛋白)<14 g/L对该法测定不干扰。该法实现了用表面活性剂为清除剂的HDL-C匀相法直接测定,在测定过程中既无明显浊度产生,也不堵塞自动分析仪的管道,而且具有良好的精密度和准确性,适合临床上推广应用。 To establish a new method of homogenous assay for HDL - C using mixed surfactants as selective reagent, after the HDL - C in serum was inhibited by the mixed surfactants, the serum CM, VLDL- C, LDL- C were hydrolyzed in the first step, the second step HDL- C was hydrolyzed and reacted to the cholesterol reagent. The results showed that the linearity of this method was up to 3.90 retool/L; The recoveries ranged from 96.2% - 103.7% ; The within - run CV ranged from 0. 65% - 2.88%, the between- run CV ranged from 1.25% - 3.56%i Comparing this method (y) with reference method (x) , we obtained the regression equation: y = 1. 010 2 x +0. 078 8, r =0. 976 2; No interference were showed when addition of isolated LDL ftaetion ( LDL - C up to 12. 8 mmol/L ) , bilirubin ( 〈 320 rag/L) and hemoglobin ( 〈 14 g/L) to pooled serum, represently. It concluded during the homogenous process of HDL - C determination using mixed surfactants as selective reagent, there was no turbidity production in the reaction system, and did not stop up the pipeline of the autoanalyzer. The method had good precision and accuracy, and suitable for clinical application.
出处 《广东微量元素科学》 CAS 2012年第8期10-13,共4页 Trace Elements Science
基金 2009年浙江省大学生科技成果推广项目(2009R413040)
关键词 表面活性剂 高密度脂蛋白胆固醇 匀相分析法 surfactant high density lipoprotein cholesterol homogenous assay
  • 相关文献

参考文献3

二级参考文献13

  • 1董军,国汉邦,王抒,李红霞,满永,张江涛,张传保,赵海舰,陈文祥.超速离心-高效液相色谱测定血清高密度和低密度脂蛋白胆固醇[J].中华检验医学杂志,2006,29(8):742-746. 被引量:14
  • 2Alsheikh -Ali AA, Lin JL, Abourjaily P,et al. Prevalence of low high - density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low - density lipoprotein cholesterol[ J]. Am J Cardiol,2007,100 : 1499 - 501.
  • 3Bachork PS, Ross TW. National cholesterol education program recommendations for measurement of low - density lipoprotein cholesterd : executive summary [ J ]. Clin Chem, 1995,41 : 1414 - 1420.
  • 4Wieland H, Seidel D. A simple speical method for precipitation of low density lipoprotein cholesterds[ J]. J Lipid Res, 1983,24:904 -909.
  • 5Warnick GR, Nauck M, Rifai N. Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays [ J ]. Clin Chem, 2001,47 ( 9 ) : 1579 - 1596.
  • 6Nauck M, Warnick GR, Rifai N. Metods for measurement of LDL- cholesterol:a critical assessment of direct measurement by homogeneous assays versus calculation [ J ]. Clin Chem, 2002,48 (2) :236 -254.
  • 7WB,中华医学检验杂志,1995年,18卷,381页
  • 8潘利琴,陈益川,连国军,赵长容,曹建明.血清总铁结合力直接光度法测定[J].中国公共卫生,2008,24(2):246-247. 被引量:3
  • 9陈文祥,李健斋.美国疾病控制与预防中心血脂标准化工作简介[J].中华医学检验杂志,1998,21(1):13-15. 被引量:16
  • 10高德路,张世俊,李培瑛.血清高密度脂蛋白胆固醇均相法测定试剂的研制[J].中华医学检验杂志,1999,22(2):104-108. 被引量:10

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部